The effects of histone deacetylase inhibitors on heterochromatin: Implications for anticancer therapy?

EMBO Reports

Volumn 6, Issue 6, 2005, Pages 520-524

  Taddei, Angela ^a,c   Roche, Danièle ^a   Bickmore, Wendy A ^b   Almouzni, Geneviève ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Anticancer therapy; Chromatin; Histone deacetylase inhibitors; Nuclear organization; Pericentric heterochromatin

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME SEGREGATION; CYTOTOXICITY; DRUG POTENCY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HUMAN; IN VITRO STUDY; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

CELL CYCLE; HETEROCHROMATIN; HISTONE DEACETYLASES; HISTONES; HYDROXAMIC ACIDS; NEOPLASMS;

ANIMALIA;

EID: 22144434077     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400441     Document Type: Article

References (33)

1. Almouzni G, Khochbin S, Dimitrov S, Wolffe AP (1994) Histone acetylation influences both gene expression and development of Xenopus laevis. Dev Biol 165: 654-669
2. Cimini D, Mattiuzzo M, Torosantucci L, Degrassi F (2003) Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. Mol Biol Cell 14: 3821-3833
3. Craig JM, Earle E, Canham P, Wong LH, Anderson M, Choo KH (2003) Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Hum Mol Genet 12: 3109-3121
4. Csankovszki G, Nagy A, Jaenisch R (2001) Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J Cell Biol 153: 773-784
5. David G, Turner GM, Yao Y, Protopopov A, DePinho RA (2003) mSin3-associated protein, mSds3, is essential for pericentric heterochromatin formation and chromosome segregation in mammalian cells. Genes Dev 17: 2396-2405
6. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749
7. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45: 495-528
8. Ekwall K, Olsson T, Turner BM, Cranston G, Allshire RC (1997) Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell 91: 1021-1032
9. Fraga MF et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37: 391-400
10. Ganesan S et al (2002) BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111: 393-405
11. Gilchrist S, Gilbert N, Perry P, Bickmore WA (2004) Nuclear organization of centromeric domains is not perturbed by inhibition of histone deacetylases. Chromosome Res 12: 505-516
12. Glaser KB, Staver MJ, Waring JF, Stender J, Ulrich RG, Davidsen SK (2003) Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther 2: 151-163
13. Ikegami S, Ooe Y, Shimizu T, Kasahara T, Tsuruta T, Kijima M, Yoshida M, Beppu T (1993) Accumulation of multiacetylated forms of histones by trichostatin A and its developmental consequences in early starfish embryos. Rouxs Arch Dev Biol 202: 144-151
14. Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, Altucci L, Nervi C, Minucci S, Pelicci PG (2005) Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 11: 71-76
15. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080
16. Kamakaka RT, Biggins S (2005) Histone variants: deviants? Genes Dev 19: 295-310
17. Kimura H, Cook PR (2001) Kinetics of core histones in living human cells: little exchange of H3 and H4 and some rapid exchange of H2B. J Cell Biol 153: 1341-1353
18. Maison C, Almouzni G (2004) HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296-304
19. Maison C, Bailly D, Peters AH, Quivy JP, Roche D, Taddei A, Lachner M, Jenuwein T, Almouzni G (2002) Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet 30: 329-334
20. Marks PA, Richon VM, Miller T, Kelly WK (2004) Histone deacetylase inhibitors. Adv Cancer Res 91: 137-168
21. McKittrick E, Gafken PR, Ahmad K, Henikoff S (2004) Histone H3.3 is enriched in covalent modifications associated with active chromatin. Proc Natl Acad Sci USA 101: 1525-1530
22. McLaughlin F, La Thangue NB (2004) Histone deacetylase inhibitors open new doors in cancer therapy. Biochem Pharmaco 168: 1139-1144
23. Mikhailov A, Shinohara M, Rieder CL (2004) Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol 166: 517-526
24. Nebbioso A et al (2005) Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med 11: 77-84
25. O'Neill LP, Keohane AM, Lavender JS, McCabe V, Heard E, Avner P, Brockdorff N, Turner BM (1999) A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. EMBO J 18: 2897-2907
26. Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD (1995) Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci USA 92: 1237-1241
27. Sogo JM, Laskey RA (1995) Chromatin replication and assembly. In Elgin SCR (ed), Chromatin Structure and Gene Expression pp 49-71. New York, NY, USA: IRL
28. Subramanian C, Opipari AW Jr, Bian X, Castle VP, Kwok RP (2005) Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 102: 4842-4847
29. Taddei A, Roche D, Sibarita JB, Turner BM, Almouzni G (1999) Duplication and maintenance of heterochromatin domains. J Cell Biol 147: 1153-1166
30. Taddei A, Maison C, Roche D, Almouzni G (2001) Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol 3: 114-120
31. Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5: 245-253
32. Warrener R, Beamish H, Burgess A, Waterhouse NJ, Giles N, Fairlie D, Gabrielli B (2003) Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. FASEB J 17: 1550-1552
33. Yoshida M, Horinouchi S, Beppu T (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17: 423-430